The week of 2026-09-21, 19 holders filed a new Schedule 13D and 36 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-09-23 | Cheer Holding, Inc. | Lioness Ltd | 100% | SCHEDULE 13D |
| 2026-09-21 | Cheetah Net Supply Chain Service Inc. | Takeover Time 2026 LLC | 62.5% | SCHEDULE 13D |
| 2026-09-22 | MBody AI Ltd. | Regan McMillan McGee | 44.9% | SCHEDULE 13D |
| 2026-09-24 | Host Digital Inc. | Hans Thomas | 38.9% | SCHEDULE 13D |
| 2026-09-24 | Host Digital Inc. | Harmol Samra | 38.9% | SCHEDULE 13D |
| 2026-09-25 | Fmc Corporation | Tessenderlo Group NV | 20% | SCHEDULE 13D |
| 2026-09-21 | PDS Biotechnology Corporation | Nant Capital, LLC | 19.9% | SCHEDULE 13D |
| 2026-09-21 | Rainmaker Worldwide Inc. | Kelly Michelle White | 16.9% | SCHEDULE 13D |
| 2026-09-24 | Real REMAX Group Inc. | David L. Liniger | 15.3% | SCHEDULE 13D |
| 2026-09-25 | Electra Therapeutics, Inc. | Orbimed Advisors LLC | 11% | SCHEDULE 13D |
| 2026-09-24 | Host Digital Inc. | Graham Capital Management, L.P. | 9.99% | SCHEDULE 13D |
| 2026-09-21 | HealthStream, Inc. | WJRJJ Ventures, LLC | 9.6% | SCHEDULE 13D |
| 2026-09-25 | Redwood Trust Inc | Amster Howard | 9% | SCHEDULE 13D |
| 2026-09-24 | TROOPS, Inc. | Lianteng Limited | 8.9% | SCHEDULE 13D |
| 2026-09-24 | TROOPS, Inc. | WANG & LEE Holdings, Inc. | 7.9% | SCHEDULE 13D |
| 2026-09-22 | TriplePoint Venture Growth BDC Corp. | TriplePoint Capital LLC | 7.42% | SCHEDULE 13D |
| 2026-09-24 | PRF Technologies Ltd. | S.H.N. Financial Investments Ltd. | 5.72% | SCHEDULE 13D |
| 2026-09-23 | URSB Bancorp, Inc. | Seidman Lawrence B | 5.4% | SCHEDULE 13D |
| 2026-09-21 | Regents Partners Income Fund IV, LP | Eckler Joe M Jr | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-09-25 | Zcash ETF | Karminski Michal Adam | 100% | SCHEDULE 13G |
| 2026-09-25 | Grayscale Near Trust (NEAR) | Karminski Michal Adam | 100% | SCHEDULE 13G |
| 2026-09-21 | Rivernorth Opportunities Fund, Inc. | Thrivent Financial For Lutherans | 24.7% | SCHEDULE 13G |
| 2026-09-25 | Live Oak Acquisition Corp. VI | Live Oak Sponsor VI, LLC | 20% | SCHEDULE 13G |
| 2026-09-22 | Jupiter Neurosciences, Inc. | PharmAla Biotech Holdings Inc. | 17.3% | SCHEDULE 13G |
| 2026-09-23 | Connetic Venture Capital Access Fund | HORAN Wealth, LLC | 11.5% | SCHEDULE 13G |
| 2026-09-21 | Nuran Wireless Inc. | Wagner Menachem | 9.9% | SCHEDULE 13G |
| 2026-09-25 | Addentax Group Corp. | Yip Wai Lun | 9.9% | SCHEDULE 13G |
| 2026-09-24 | Private Bancorp of America, Inc. | Ernest Rady Trust U/D/T March 10, 1983 | 9.8% | SCHEDULE 13G |
| 2026-09-25 | Leader's Advantage Acquisition Corp | Sculptor Capital LP | 9.77% | SCHEDULE 13G |
| 2026-09-23 | SCWorx Corp. | Mitchell P. Kopin | 9.1% | SCHEDULE 13G |
| 2026-09-22 | BetterLife Pharma Inc. | RA Capital Management, L.P. | 9% | SCHEDULE 13G |
| 2026-09-21 | Haymaker Acquisition Corp V | MMCAP International Inc. SPC | 8.8% | SCHEDULE 13G |
| 2026-09-21 | Leader's Advantage Acquisition Corp | MMCAP International Inc. SPC | 8.6% | SCHEDULE 13G |
| 2026-09-21 | Arxis, Inc. | Gerald W. Simonson Revocable Trust Agreement Dated May 12, 2016 as amended | 8.6% | SCHEDULE 13G |
| 2026-09-24 | Host Digital Inc. | Alexander Monje | 8.6% | SCHEDULE 13G |
| 2026-09-22 | Cyabra, Inc. | RainForest Partners LLC | 8.4% | SCHEDULE 13G |
| 2026-09-22 | Cyabra, Inc. | The Hewlett Fund LP | 8.3% | SCHEDULE 13G |
| 2026-09-25 | TeraWulf Inc. | Google LLC | 7.6% | SCHEDULE 13G |
| 2026-09-22 | Advanced Biomed Inc. | Lee Chen Yi | 7.5% | SCHEDULE 13G |
| 2026-09-23 | Alpha Cognition Inc. | James E. Besser | 7.4% | SCHEDULE 13G |
| 2026-09-21 | Tyra Biosciences, Inc. | Bvf Partners L P | 6.1% | SCHEDULE 13G |
| 2026-09-21 | Marinemax Inc | Emma Omega Ltd | 6.1% | SCHEDULE 13G |
| 2026-09-25 | Haymaker Acquisition Corp V | Linden Advisors LP | 6.1% | SCHEDULE 13G |
| 2026-09-21 | X4 Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 5.6% | SCHEDULE 13G |
| 2026-09-22 | Better Home & Finance Holding Company | Millennium Management LLC | 5.5% | SCHEDULE 13G |
| 2026-09-23 | Haymaker Acquisition Corp V | Millennium Management LLC | 5.5% | SCHEDULE 13G |
| 2026-09-24 | BioLife Solutions, Inc. | Glazer Capital, LLC | 5.49% | SCHEDULE 13G |
| 2026-09-21 | Aclaris Therapeutics, Inc. | Frazier Life Sciences Public Fund, L.P. | 5.4% | SCHEDULE 13G |
| 2026-09-25 | TScan Therapeutics, Inc. | Readout Capital, LP | 5.4% | SCHEDULE 13G |
| 2026-09-25 | The Baldwin Insurance Group, Inc. | Glazer Capital, LLC | 5.35% | SCHEDULE 13G |
| 2026-09-23 | Nurix Therapeutics, Inc. | Perceptive Advisors LLC | 5.3% | SCHEDULE 13G |
| 2026-09-21 | Werewolf Therapeutics, Inc. | Moll Peter | 5.2% | SCHEDULE 13G |
| 2026-09-23 | Array Digital Infrastructure, Inc. | Hawk Ridge Capital Management LP | 5.1% | SCHEDULE 13G |
| 2026-09-21 | Cricut, Inc. | Steven Blasnik | 5.09% | SCHEDULE 13G |
| 2026-09-24 | Ip Strategy Holdings, Inc. | Jane Street Group, LLC | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.